FMP

FMP

Enter

FATE - Fate Therapeutics, Inc.

Valuation of Fate Therapeutics, Inc.(FATE), Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular im

Valuation Date:

Mar 28, 2024 12:23 PM

Share Price on Valuation Date

$7.46

Stock Beta

1.668

Shares Outstanding

99237500

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep